Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
OPERATING EXPENSES
Research and development	$ 1,493,200	$ 1,012,085	$ 3,066,271	$ 2,494,490
General and administrative	798,722	622,347	1,496,034	1,127,819
Total operating expenses	2,291,922	1,634,432	4,562,305	3,622,309
LOSS FROM OPERATIONS	(2,291,922)	(1,634,432)	(4,562,305)	(3,622,309)
OTHER INCOME (EXPENSE)
Interest income	1,187	784	4,246	6,001
Interest expense	(37,293)	(4,131)	(81,202)	(4,131)
Loss on disposal of property and equipment	(2,026)		(2,026)	0
Loss on issuance of Series A preferred stock for accounts payable - related party		(142,669)	0	(142,669)
Change in fair value of derivative liability		(147,078)		274,449
Other (expense) income	(38,132)	(293,094)	(78,982)	133,650
LOSS BEFORE INCOME TAX PROVISION	(2,330,054)	(1,927,526)	(4,641,287)	(3,488,659)
INCOME TAX PROVISION	0	0	0	0
NET LOSS	$ (2,330,054)	$ (1,927,526)	$ (4,641,287)	$ (3,488,659)
NET LOSS PER COMMON SHARE
Net loss per common share- basic and diluted	$ (0.22)	$ (0.50)	$ (0.44)	$ (0.91)
Weighted average common shares outstanding
Weighted average common shares outstanding - basic and diluted	10,666,056	3,853,858	10,576,828	3,849,437